UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 92

Sortiert nach

Design of the REVEAL Registry for US Patients With Pulmonary Arterial Hypertension

Mayo Clinic proceedings, 2008-08, Vol.83 (8), p.923-931

2008

Link zum Volltext

Verfügbarkeit prüfen

Pulmonary Arterial Hypertension: Diagnosis and Evidence-Based Treatment

Barst, Robyn

1, 2008

Link zum Volltext

Verfügbarkeit prüfen

Tadalafil for the Treatment of Pulmonary Arterial Hypertension

Journal of the American College of Cardiology, 2012-08, Vol.60 (8), p.768-774

2012

Link zum Volltext

Verfügbarkeit prüfen

Clinical trials in neonates and children: Report of the pulmonary hypertension academic research consortium pediatric advisory committee

Pulmonary circulation, 2013-01, Vol.3 (1), p.252-266

2013

Link zum Volltext

Verfügbarkeit prüfen

Clinical perspectives with long-term pulsed inhaled nitric oxide for the treatment of pulmonary arterial hypertension

Pulmonary Circulation, 2012-04, Vol.2 (2), p.139-147

2012

Link zum Volltext

Verfügbarkeit prüfen

Pulmonary hypertension: past, present and future

Annals of thoracic medicine, 2008-01, Vol.3 (1), p.1-4

Barst, Robyn J

2008

Link zum Volltext

Verfügbarkeit prüfen

Demographics and Outcomes of Patients Diagnosed With Pulmonary Hypertension With Pulmonary Capillary Wedge Pressures 16 to 18 mm Hg

Chest, 2013, Vol.143 (1), p.185-195

2013

Link zum Volltext

Verfügbarkeit prüfen

Classification of pediatric pulmonary hypertensive vascular disease: Does it need to be different from the adult classification?

Pulmonary circulation, 2011-04, Vol.1 (2), p.134-137

Barst, Robyn J.

2011

Link zum Volltext

Verfügbarkeit prüfen

Repair of congenital heart disease with associated pulmonary hypertension in children: what are the minimal investigative procedures? Consensus statement from the Congenital Heart Disease and Pediatric Task Forces, Pulmonary Vascular Research Institute (PVRI)

Pulmonary circulation, 2014-06, Vol.4 (2), p.330-341

2014

Link zum Volltext

Verfügbarkeit prüfen

Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension

Circulation (New York, N.Y.), 1997-03, Vol.95 (6), p.1479-1486

1997

Link zum Volltext

Verfügbarkeit prüfen

Portopulmonary Hypertension

Chest, 2012-04, Vol.141 (4), p.906-915

2012

Link zum Volltext

Verfügbarkeit prüfen

Long-term Treatment With Sildenafil Citrate in Pulmonary Arterial Hypertension

Chest, 2011-11, Vol.140 (5), p.1274-1283

2011

Link zum Volltext

Verfügbarkeit prüfen

The Changing Picture of Patients With Pulmonary Arterial Hypertension in the United States

Chest, 2011, Vol.139 (1), p.128-137

2011

Link zum Volltext

Verfügbarkeit prüfen

Pediatric pulmonary hypertension

Türk Kardiyoloji Derneği arşivi, 2014-10, Vol.42 Suppl 1, p.153-164

2014

Link zum Volltext

Verfügbarkeit prüfen

New trial designs and potential therapies for pulmonary artery hypertension

Türk Kardiyoloji Derneği arşivi, 2014-10, Vol.42 Suppl 1, p.106-118

2014

Link zum Volltext

Verfügbarkeit prüfen

Pulmonary Arterial Hypertension

Chest, 2010-02, Vol.137 (2), p.376-387

2010

Link zum Volltext

Verfügbarkeit prüfen

Sitaxsentan for the Treatment of Pulmonary Arterial Hypertension

Chest, 2008-10, Vol.134 (4), p.775-782

2008

Link zum Volltext

Verfügbarkeit prüfen

Sitaxsentan: a novel endothelin-A receptor antagonist for pulmonary arterial hypertension

Expert review of cardiovascular therapy, 2005-11, Vol.3 (6), p.985-991

2005

Link zum Volltext

Verfügbarkeit prüfen

ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension

Journal of the American College of Cardiology, 2009-04, Vol.53 (17), p.1573-1619

2009

Link zum Volltext

Verfügbarkeit prüfen

Safety and Efficacy of IV Treprostinil for Pulmonary Arterial Hypertension

Chest, 2006-03, Vol.129 (3), p.683-688

2006

Link zum Volltext

Verfügbarkeit prüfen

Sustained Symptomatic, Functional, and Hemodynamic Benefit With the Selective Endothelin-A Receptor Antagonist, Sitaxsentan, in Patients With Pulmonary Arterial Hypertension

Chest, 2004-10, Vol.126 (4), p.1377-1381

2004

Link zum Volltext

Verfügbarkeit prüfen

Identical Twins With Primary Pulmonary Hypertension

Chest, 2004-03, Vol.125 (3), p.1157-1159

2004

Link zum Volltext

Verfügbarkeit prüfen

Medical Therapy For Pulmonary Arterial Hypertension

Chest, 2004-07, Vol.126 (1), p.35S-62S

2004

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis and assessment of pulmonary hypertension in infants and children

Progress in pediatric cardiology, 2001, Vol.12 (3), p.279-288

Barst, Robyn J

2001

Link zum Volltext

Verfügbarkeit prüfen

Clinical Efficacy of Sitaxsentan, an Endothelin-A Receptor Antagonist, in Patients With Pulmonary Arterial Hypertension

Chest, 2002-06, Vol.121 (6), p.1860-1868

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 92

Suche als RSS-Feed

Aktive Filter

ThemaHumans

ThemaPneumology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(91)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Design of the REVEAL Registry for US Patients With Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension: Diagnosis and Evidence-Based Treatment

Tadalafil for the Treatment of Pulmonary Arterial Hypertension

Clinical trials in neonates and children: Report of the pulmonary hypertension academic research consortium pediatric advisory committee

Clinical perspectives with long-term pulsed inhaled nitric oxide for the treatment of pulmonary arterial hypertension

Pulmonary hypertension: past, present and future

Demographics and Outcomes of Patients Diagnosed With Pulmonary Hypertension With Pulmonary Capillary Wedge Pressures 16 to 18 mm Hg

Classification of pediatric pulmonary hypertensive vascular disease: Does it need to be different from the adult classification?

Repair of congenital heart disease with associated pulmonary hypertension in children: what are the minimal investigative procedures? Consensus statement from the Congenital Heart Disease and Pediatric Task Forces, Pulmonary Vascular Research Institute (PVRI)

Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension

Portopulmonary Hypertension

Long-term Treatment With Sildenafil Citrate in Pulmonary Arterial Hypertension

The Changing Picture of Patients With Pulmonary Arterial Hypertension in the United States

Pediatric pulmonary hypertension

New trial designs and potential therapies for pulmonary artery hypertension

Pulmonary Arterial Hypertension

Sitaxsentan for the Treatment of Pulmonary Arterial Hypertension

Sitaxsentan: a novel endothelin-A receptor antagonist for pulmonary arterial hypertension

ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension

Safety and Efficacy of IV Treprostinil for Pulmonary Arterial Hypertension

Sustained Symptomatic, Functional, and Hemodynamic Benefit With the Selective Endothelin-A Receptor Antagonist, Sitaxsentan, in Patients With Pulmonary Arterial Hypertension

Identical Twins With Primary Pulmonary Hypertension

Medical Therapy For Pulmonary Arterial Hypertension

Diagnosis and assessment of pulmonary hypertension in infants and children

Clinical Efficacy of Sitaxsentan, an Endothelin-A Receptor Antagonist, in Patients With Pulmonary Arterial Hypertension

Aktive Filter

Suchergebnisse filtern